• #LGM Pharma is a Amlodipine Besylate CAS# 111470-99-6 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, delivery, purity, and more.
  • #Questions? Call our customer API support number 1-(800)-881-8210.
  • #LGM Pharma offers this active ingredient but not the finished dosage forms.

Product Details:

  • CAS No: 111470-99-6
  • AHFC code:
  • Synonyms: 2-[(2-AMINOETHOXY)-METHYL]-4-(2-CHLOROPHENYL)-1,4-DIHYDRO-6-METHYL-3,5-PYRIDINEDICARBOXYLIC ACID 3-ETHYL 5-METHYL ESTER BENZENE SULFONATE, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine benzenesulfonate, AMLODIPINE BENZENESULFONATE, AMLODIPINE BESILATE, AMLODIPINE BESYLATE, NORVASC, 3,5-pyridinedicarboxylicacid,2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1, 4-dihydro-6-methyl-,3-ethyl-5-methylester,monobenzenesulfonate, AMLODIPINE BESILATE MM(CRM STANDARD), AMLODIPINE BESYLATE EPY(CRM STANDARD), 2-[(2-aminoethoxy)-methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester benzene sulfonate, AMLODIPINEBESYLATE(SUBJECTTOPATENTFREE), (+-)-3-Ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate monobenzenesulfonate, 3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester, monobenzenesulfonate, Amcard, Amdepin, Amdipin, Amlodin, Amlopin, Amlor
  • ATC Code: C08CA01
  • Chemical Formula: C20H25ClN2O5.C6H6O3S
  • Molecular Weight: 567.05
  • Assay/Purity: Typically NLT 98%
  • DrugBank: APRD00520
  • SMILES:
  • InChl:
  • PubChem: 60496
  • IUPAC: 2-[(2-Aminoethoxy)methyl]-4-(2-chlo rophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarbo xylic acid 3-ethyl 5-methyl ester benzenesulfonate

Additional Details

Indication:
Pharmacodynamics:
Mode of Action:
L-type calcium channel blocker that displays antihypertensive properties. Inhibits Ca2+-induced contractions in depolarized rat aorta (IC50 = 1.9 nM) and displays vasoprotective effects in cardiovascular disease. Inhibits proliferation of human vascular smooth muscle cells and epidermoid carcinoma A431 cells (IC50 = 25 μM).
Metabolism:
Toxicity:
General Reference:
Arrowsmith, J.E., et al. 1986. J. Med. Chem. 29: 1696-1702. PMID: 2943898 Burges, R.A., et al. 1987. J. Cardiovasc. Pharmacol. 9: 110-119. PMID: 2434785 Packer, M., et al. 1996. N. Engl. J. Med. 335: 1107-1114. PMID: 8813041 Yoshida, J., et al. 2003. Eur. J. Pharmacol. 472: 23-31. PMID: 12860469 Toba, H., et al. 2005 Hypertens. Res. 28: 689-700. PMID: 16392774
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Cost effective materials based on specific requirements
  • Small quantities for initial research and larger development quantities towards product commercialization

 

  • Technical packages, letters of access to filed DMFs
  • Complete assistance in any regulatory filings
  • Top quality GMP certified manufacturers
  • Have necessary regulatory credentials